Overexpression of c-Src in areas of hyperproliferation in head and neck cancer, premalignant lesions and benign mucosal disorders

Journal of Oral Pathology and Medicine

Volumn 27, Issue 4, 1998, Pages 147-152

  Van Oijen, M G C T ^a   Rijksen, G ^a   Ten Broek, F W ^a   Slootweg, P J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

c Src; Head and neck cancer; Immunohistochemistry; Oral mucosa; Proliferation; Tumorigenesis

Indexed keywords

EID: 0032054511     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1998.tb01931.x     Document Type: Article

References (28)

1. FIELD JK. The role of oncogenes and tumour-supressor genes in the aetiology of oral, head and neck squamous cell carcinoma. J R Soc Med 1995; 88: 35-9.
2. PAPADIMTRAKOPOULOU VA, SHIN DM, HONG WK. Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorgenesis. Cancer Metast Rev 1996; 15: 53-76.
3. SLAUGHTER DP, SOUTHWICK HW, SMEJKAL W. "Field cancerization" in oral stratified squamous epithelium. Cancer 1953; 6: 963-8.
4. VERSCHUUR HP, RIJKSEN G, SCHIPPER-KESTER GP, SLOOTWEG PJ, HORDUK GJ, STAAL GEJ. Protein tyrosine activity in laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 1993; 249: 466-9.
5. TONKS NK, CHARBONNEAU H. Protein tyrosine phosphorylation and signal transduction. TIBS 1989; 14: 497-500.
6. SHIN DM, RO JY, HONG WK, NITTELMAN WN. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 1994; 54: 3153-9.
7. VAN OIJEN MGCT, RIJKSEN G, TEN BROEK FW, SLOOTWEG PJ. Increased expression of epidermal growth factor receptor in normal epithelium adjacent to head and neck carcinomas independent of tobacco and alcohol abuse. Oral Dis: in press.
8. VERBEEK BS, VROOM TM, ADRIAANSENSLOT SS, et al. C-Src protein expression is increased in human breast cancer. J Pathol 1996; 180: 383-8.
9. ROSS W, HALL PA. Ki67: from antibody to molecule to understanding. J Clin Path Mol Pathol 1995; 48: M113-7.
10. SHIN DM, VORAVUD N, RO JY, LEE JS, HONG WK, HITTELMAN WN. Sequential increase in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. J Natl Cancer Inst 1993; 12: 971-8.
11. ERPEL T, COURTNEIDGE SA. Src family protein tyrosine kinases and cellular signal transduction pathways. Curr Opin Cell Biol, Cell Regulation 1995; April: 176-82.
12. WEBER TK, STEELE G, SUMMERHAYES IC. Differential pp60c-src activity in well and poorly differentiated human colon carcinomas and cell lines. J Clin Invest 1992; 90: 815-21.
13. CARTWRIGHT CA, MEISLER AI, ECKHART W. Activation of the pp60c-src protein kinase is an early event in colon carcinogenesis. Proc Natl Acad Sci USA 1990; 87: 558-62.
14. c-src in human small cell and non-small cell lung carcinomas. Eur J Cancer 1992; 28: 372-7.
15. c-src in low grade human bladder carcinomas. Cancer Res 1992; 52: 1457-62.
16. CARTWRIGHT CA, COAD CA, EGBERT BM. Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis. J Clin Invest 1994; 93: 509-15.
17. SHENOY S, CHAKALAPAMPIL I, BAGRODIA S, LIN PH, SHALLOWAY D. Role of p34cdc2-mediated phosphorylations in two-step activation of pp60c-src during mitosis. Proc Natl Acad Sc USA 1992; 89: 7237-41.
18. cdc2 in the cells of normal, hyperplastic and malignant epithelial and lymphoid tissues of the oral cavity. J Pathol 1996; 178: 422-8.
19. c-src activity in human colon tumor cell lines. Oncogene 1991; 6: 1983-9.
20. AKIYAMA T, ISHTDA J, NAKAGAWA S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987; 262: 5592-5.
21. SREEKANTAIAH C, RAO PH, SACKS PG, SCHANTZ SP, CHAGANTI SK. Consistent chromosomal losses in head and neck squamous cell carcinoma cell lines. Genes Chromosomes Cancer 1994; 11: 29-39.
22. SAKAGUCHI AY, MOHANDAS T, NAYLOR SL. A human c-src gene resides on the proximal long arm of chromosome 20 (cen-q131). Cancer Genet Cytogenet 1985; 18: 123-9.
23. KAPLAN KB, SWEDLOW JR, VARMUS HE, MORGAN DO. Association of p60c-src with endosomal membranes in mammalian fibroblasts. J Biol Chem 1992; 118: 321-33.
24. OUDE WEERNINK PA, RIJKSEN G. Activation and translocation of c-Src to the cytoskeleton by both platelet-derived growth factor and epidermal growth factor. J Biol Chem 1995; 270: 2264-7.
25. DAVID-PFEUTY T, BAGRODIA S, SHALLOWAY D. Differential localization patterns of myristoylated and nonmyristoylated c-Src proteins in interphase and mitotic c-Src overexpressor cells. J Cell Sci 1993; 105: 613-28.
26. OUDE WEERNIKK PA, OTTENHOFF-KALF AE, VENDRIG MP, VAN BEURDEN EA, STAAL GE, RIJKSEN G. Functional interaction between the epidermal growth factor receptor and c-Src kinase activity. FEBS Lett 1994; 352: 296-300.
27. WASILENKO WJ, PAYNE DM, FITZGERALD DL, WEBER MJ. Phosphorylation and activation of epidermal growth factor receptors in cells transformed by the src oncogene. Mol Cell Biol 1991; 11: 309-21.
28. MAA M, LEU T, MCCARLEY DJ, SCHATZMAN RC, PARSONS SJ. Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers. Proc Natl Acad Sci USA 1995; 92: 6981-5.